The effect of rifampin administration on the disposition of fexofenadine

Clinical Pharmacology and Therapeutics

Volumn 69, Issue 3, 2001, Pages 114-121

  Hamman, Mitchell A ^a   Bruce, Melissa A ^a   Haehner Daniels, Barbara D ^a   Hall, Stephen D ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACYCLONOL; CLARITHROMYCIN; CYCLOSPORIN; CYTOCHROME P450 3A4; ERYTHROMYCIN; FEXOFENADINE; GLYCOPROTEIN P; KETOCONAZOLE; MEVINOLIN; RIFAMPICIN; RITONAVIR; UNCLASSIFIED DRUG; VERAPAMIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CROSS REACTIVITY; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; KIDNEY CLEARANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; AGING; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HALF-LIFE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; METABOLIC CLEARANCE RATE; P-GLYCOPROTEIN; RIFAMPIN; SEX CHARACTERISTICS; TERFENADINE;

EID: 0035107449     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.113697     Document Type: Article

References (20)

1. Mass balance and pharmacokinetics of MDL 16455A in healthy male volunteers
2. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
3. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
4. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
5. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
6. Gender effects in pharmacokinetics and pharmacodynamics
7. Effect of age, gender and obesity on midazolam kinetics
8. Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and high performance liquid chromatography with fluorescence detection
9. Renal function
10. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve
11. Mechanism of the cardiotoxic actions of terfenadine
12. Human MDR1 and mouse mdrla P-glycoprotein alter the cellular retention and disposition of erythromycin, but not retinoic acid or benz(a)pyrene
13. Organic cation transporters in intestine, kidney, liver, and brain
14. Rat pregnane X receptor: Molecular cloning, tissue distribution, and xenobiotic regulation
15. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
16. Effect of age and gender on the activity of human hepatic CYP3A
17. Clarithromycin pharmacokinetics in healthy young and elderly volunteers
18. Interindividual variation in expression of P-glycoprotein in normal liver and secondary hepatic neoplasms
19. Fexofenadine disposition is similar between caucasian (C) and African-American (AA) men and women
20. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers